Cardiovascular Diseases

Articles

2018. Davies EW et al. – Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension

2018. Kay G et al. – Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

2017. Alemao E et al. – Comparison of cardiovascular risk algorithms in patients with vs. without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis

2017. Burnett H et al. – Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: A network meta-analysis

2016. Alemao E et al. – Cardiovascular risk factor management in patients with RA compared to matched non-RA patients

2013. Swinburn P et al – Assessing the health-related quality of life in patients hospitalised for acute heart failure

2013. Bonner N et al. – Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients

2013. Kinnaird T et al. – Relative efficacy of bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: A network meta-analysis

2013. Schouten HJ et al. – Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: Systematic review and meta-analysis

2012. Bruckert E et al. – Time for implementation of hypolipemiant treatment in patient with dyslipidemia in general medicine: Results of the Prysme study

2009. Prins MH et al. – Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: The ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q)

2009. Prins MH et al. – Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©)

Posters & Presentations

2017. ISPOR European Congress – Cost-effectiveness of dabigatran with real world effectiveness evidence

2017. ISPOR Annual International Meeting – A systematic literature review on carcinoïd heart disease in patients with carcinoïd syndrome

2017. ENETS Annual Conference – Epidemiology of carcinoïd heart disease (CHD) in patients (pts) with carcinoïd syndrome (CS): A systematic literature review

2017. ENETS Annual Conference – What do we know about carcinoïd heart disease? A systematic literature review

2016. ISPOR European Congress – Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using a Mixed Methods Design: An Example in a Rare Cardiac Clinical Trial

2016. ISOQOL Annual Conference – Qualitative Research to Explain Quantitative Results: An Example of Triangulation in the Case of a Rare Cardiac Disease

2016. MMIRA Conference – How Can Qualitative Data Help Explain Quantitative Results? An Example of Triangulation Analysis in the Case of a Rare Cardiac Disease

2016 – ESC Heart Failure Congress – Systematic Assessment of Heart Failure Data Sources across 120 Countries: Analysis of their Suitability for Real-World Evidence Research

2015. ISPOR Annual International Meeting – Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry

2014. ISPOR European Congress – The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta- Analysis Comparing Pharmacological Treatments for Chronic Heart Failure

2014. ISPOR European Congress – Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials

2014. ISPOR Annual International Meeting – Comparative Efficacy of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation among Patients with Prior Stroke or Systemic Embolism

2014. ISPOR Annual International Meeting – A Network Meta-Analysis Evaluating the Cumulative Hazard Rate of Stroke or Systemic Embolism for New Oral Anticoagulants in Stroke Prevention for Atrial Fibrillation

2014. ESC Heart Failure Congress – Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations: Network Meta-Analyses.

2013. European Society of Cardiology Congress – Relative efficacy of bivalirudin vs. heparin monotherapy in STEMI patients treated with primary percutaneous coronary intervention. A network meta-analysis

2012. ISPOR European Congress – Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations: Network Meta-Analyses

2011. ISPOR European Congress – How Patients with Chronic Stable Angina Perceive and Live with their Disease on an Everyday Basis?

2011. ISPOR European Congress – Evaluation of the Measurement Properties of the Antihypertensive Adherence Survey

2011. ISPOR European Congress – Relative Efficacy of Bivalirudin vs. Heparin Alone in STEMI Patients Treated with Primary PCI – An Indirect Treatment Comparison

2011. ISPOR European Congress – Validation of a Patient-Reported Outcome (PRO) Measure and a Clinician-Reported Outcome (CRO) Measure to Assess Satisfaction and Preference with Pharmalogical Stress Agents for Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

2011. ISOQOL Annual Conference – Development of a Patient-Reported Outcome Measure and A Clinician-Reported Outcome Measure to Assess Satisfaction and Preference with Pharmacological Stress Agents for Single Photon Emission Computed Tomography Myocardial Perfusion Imaging

2009. ISPOR European Congress – Exploring Patients’ Satisfaction with Anticoagulant Treatment by Applying Structural Equation Models to the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).

2009. ISPOR Annual International Meeting – Cost- Effectiveness of Valsartan in Japan: Results from the JIKEI Heart Study

2008. ISPOR Annual International Meeting – Convenience of the New Long- Acting Anticoagulant Idraparinux Versus Vitamin K Antagonist in Patients with Atrial Fibrillation

2006. ISPOR European Congress – Characterization of Hypertensive Patients who Might Benefit from a Combination of Two Drugs in One Pill for Reduction of Cardiovascular Risk

2006. ISPOR European Congress – The Effectiveness of Rosuvastatin Compared with Other Statins – Results from a Routine Clinical Practice Setting in the UK

2005. ISPOR European Congress – A Literature Review of Patient-Reported Outcomes (PRO) Used in Atrial Fibrillation

2005. ISPOR European Congress – A Literature Review of Patient-Reported Outcomes (PRO) Used in Atrial Fibrillation

2005. ISPOR European Congress – When Should Patients be Switched from VKA to New Treatment: Development and Pilot Testing of a Self-Reported Questionnaire to Target Patients Who Would Benefit Most

1999. ISPOR Annual International Meeting – A Comparison of the EMEA and FDA Draft Guidelines in Congestive Heart Failure (CHF) with Particular Reference to Quality of Life (QOL) Outcomes